89bio Inc Cash Flow-to-Debt Ratio
89bio Inc cash flow-to-debt ratio. 89bio Inc (ETNB) has a Cash Flow-to-Debt Ratio of -1.23x as of June 2025, meaning its operating cash flow of $-100.42 Million could theoretically repay -1% of its total liabilities ($81.75 Million) in one year. See 89bio Inc (ETNB) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of 89bio Inc (2018–2024)
Cash flow-to-debt ratio of 89bio Inc from 2018 to 2024. Historical debt coverage capacity for 89bio Inc across 7 annual periods. Also explore ETNB year-over-year net asset growth to track the company's year-over-year net asset growth rate.
89bio Inc Cash Flow-to-Debt Ratio by Year (2018–2024)
89bio Inc cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for 89bio Inc. For the full cash flow conversion analysis, see ETNB cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.72x | $-367.82 Million | $77.90 Million | ▼ -119.2% |
| 2023 | -2.15x | $-129.19 Million | $59.96 Million | ▼ -19.5% |
| 2022 | -1.80x | $-81.09 Million | $44.99 Million | ▲ +14.4% |
| 2021 | -2.11x | $-76.78 Million | $36.47 Million | ▲ +63.1% |
| 2020 | -5.70x | $-46.24 Million | $8.11 Million | ▼ -25.6% |
| 2019 | -4.54x | $-25.46 Million | $5.61 Million | ▼ -898.4% |
| 2018 | -0.45x | $-12.47 Million | $27.43 Million | — |